Navigation Links
Janssen Labs at San Diego Expands to Add Concept Lab and Open Collaboration Space to Accommodate Individual Entrepreneurs and Additional Life Science Start-Ups
Date:2/5/2013

st Research Center.  "We are confident that the important work taking place within the labs and offices of this collaborative environment will serve patients worldwide by delivering novel solutions to significant unmet medical needs." 

The entrepreneurs utilizing the Concept Lab and the Open Collaboration Space can quickly begin their work in a capital-efficient manner and have the flexibility to move into a larger, private space at Janssen Labs when they require a larger footprint.  

Janssen Labs at a Glance
Janssen Labs currently has a total of 18 companies pursing novel technologies in the life sciences, including therapeutics, medical devices, diagnostics, tools and instrumentation.

  • 32,000-square foot life science innovation center
  • Modular Space: Modular wet lab units with access to specialized capital equipment and administrative areas
  • Concept Lab: Affordable shared laboratory with single bench spaces
    • Capacity to accommodate approximately 10 entrepreneurs
  • Open Collaboration Space: Open-plan office setting with desk space, cubicles, conference rooms
    • Capacity to accommodate at least 20 entrepreneurs
  • Growth & Progress
    • To date, one company has grown into a larger space within Janssen Labs and one company has already graduated to a larger, independent off-site facility. 
  • Applications: Currently accepting applications for all spaces. Visit www.janssenlabs.com.

About Janssen Labs at San Diego
Janssen Labs at San Diego, located at the Janssen Research & Development West Coast Research Center, is a life science innovat
'/>"/>

SOURCE Janssen Research & Development, LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Janssen Research & Development Submits XARELTO® (rivaroxaban) to U.S. FDA for the Treatment and Prevention of Recurrent Venous Thromboembolism
2. Janssen Research & Development Submits New Drug Application to U.S. FDA for Canagliflozin to Treat Patients with Type 2 Diabetes
3. Janssen Announces Initiation Of Phase 3 Development Program For Sirukumab In Rheumatoid Arthritis
4. Janssen Biotech Announces Global License and Development Agreement for Investigational Anti-Cancer Agent Daratumumab
5. West Announces Agreement with Janssen Biotech to Develop and Commercialize a New Self-injection Technology
6. Janssen Announces Collaboration with Vertex on Phase 2 Study to Investigate an All-Oral Regimen of Simeprevir (TMC435) and VX-135 for Treatment of Hepatitis C
7. Janssen and Johnson & Johnson to Provide Webcast Presentation of Immunology Pivotal Phase 3 Data Being Presented at the American College of Rheumatology Annual Meeting
8. Efficacy and Safety Data from Phase 2B Trials of Janssens Simeprevir in Hepatitis C Patients with Advanced Fibrosis of the Liver Presented at Annual Meeting of the American Association for the Study of Liver Diseases
9. Janssen Research & Development Announces Establishment of Global Cross-Pharmaceutical Clinical Trial Investigator Databank
10. Janssen Research & Development Submits New Drug Application to U.S. FDA for Canagliflozin/Metformin Fixed-Dose Combination Therapy to Treat Patients with Type 2 Diabetes
11. San Diego Based Neurosurgeon Offers Groundbreaking Treatment to Restore Function for People Suffering from Mobility Inhibiting Paralysis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... PRINCETON, N.J. , Dec. 24, 2014 /PRNewswire/ ... Company), a late-stage biopharmaceutical company developing products that ... inflammation, oncology and biodefense, announced today that on ... registered public offering. The Company raised ... offering and intends to use the net proceeds ...
(Date:12/24/2014)... FARMINGTON, Conn. , Dec. 24, ... PTN), a biopharmaceutical company developing targeted, receptor-specific peptide ... unmet medical need and commercial potential, today announced ... of 2,050,000 shares of its common stock and ... its common stock.  Funds under the management of ...
(Date:12/24/2014)... Wash. , Dec. 23, 2014  Advanced ... development company engaged primarily in the development of ... therapeutic applications, today announced that it has filed ... Food and Drug Administration ("FDA") for marketing clearance ... Section 513(f)(2) of the U.S. Food, Drug and ...
Breaking Medicine Technology:Soligenix Announces Closing of Public Offering of Units 2Soligenix Announces Closing of Public Offering of Units 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 2Palatin Completes $20 Million Equity and $10 Million Debt Financings 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 4Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 2Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 3
... in Neurogastroenterology and Motility- MONTVALE, N.J., Oct. ... announced today the publication of,preclinical data demonstrating the ... of advanced glycated end-products (AGEs) and restore,neuronal nitric ... Loss,of gastrointestinal nNOS activity is one of the ...
... nearly 80% of patients, SAN FRANCISCO, Oct. 24 ... data from an ongoing phase 2,trial of XL880, an ... renal cell carcinoma (PRC). Of 19 patients with measurable,disease ... decrease in,tumor size (4-33%), including one patient with a ...
Cached Medicine Technology:Synvista Therapeutics' Alagebrium Shows Potential for use in Treating Diabetes-Related Gastrointestinal Complications 2Synvista Therapeutics' Alagebrium Shows Potential for use in Treating Diabetes-Related Gastrointestinal Complications 3Synvista Therapeutics' Alagebrium Shows Potential for use in Treating Diabetes-Related Gastrointestinal Complications 4Interim Phase 2 Data for Exelixis' XL880 Show Anti-Tumor Activity in Papillary Renal Cell Cancer 2Interim Phase 2 Data for Exelixis' XL880 Show Anti-Tumor Activity in Papillary Renal Cell Cancer 3Interim Phase 2 Data for Exelixis' XL880 Show Anti-Tumor Activity in Papillary Renal Cell Cancer 4Interim Phase 2 Data for Exelixis' XL880 Show Anti-Tumor Activity in Papillary Renal Cell Cancer 5
(Date:12/25/2014)... December 26, 2014 This is a ... the global Sterilizers industry with a focus on the ... market status of the Sterilizers manufacturers and is a ... individuals interested in the industry. This report provides a ... and manufacturing technology. In this part, the report presents ...
(Date:12/25/2014)... months the trends for evening dresses shift and ... of the hottest styles in the next few months.” The ... 26 A-line sweetheart evening dresses, and announces the availability of ... trying our best to help a lady to show off ... prices, we provide discounted delivery costs to our customers worldwide. ...
(Date:12/25/2014)... BambooFlooringChina.com sells many bamboo products and the ... the company announces big discounts on its bamboo ... , BambooFlooringChina.com is the world’s leader in bamboo flooring. ... until Jan. 20, 2015. , The bamboo mats are ... natural thread. All the bamboo strips for the mats ...
(Date:12/25/2014)... 25, 2014 (HealthDay News) -- The risk of burns ... so you need to be extra cautious, an expert ... see a significant increase in patients coming in with ... Suffolk County Volunteer Firefighters Burn Center of Stony Brook ... be full of joy, but if not careful, could ...
(Date:12/25/2014)... Thousands of transvaginal mesh lawsuits ( ... number of multidistrict litigations currently underway in U.S. District ... reports. According to an Order issued on December 2, ... Status Conference in all of the proceedings on January ... to submit a proposed agenda to the Court by ...
Breaking Medicine News(10 mins):Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 3Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2Health News:Don't Let Burns Mar Your Holidays 2Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 3Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 4
... fax orders and associated manual processes in healthcare supply ... customersMISSISSAUGA, Ontario and LOUISVILLE, Colo., Jan. 29 ... fax conversion service to streamline the electronic integration and ... Converting manual fax orders to electronic data interchange (EDI) ...
... Va., Jan. 29 CSC (NYSE: ... benchmarking tool that enables hospitals to analyze how ... areas. The application also provides hospital administrators with ... and improving healthcare delivery. The new tool, available ...
... FRANCISCO, Jan. 29 The SCAN Foundation has awarded ... establish the nation,s first center devoted exclusively to advancing ... community-based care for seniors. "There is a looming crisis ... needs of aging baby boomers," said Bruce Chernof, M.D., ...
... Dietetic Association, the nation,s largest association of food and ... Dietary Guidelines for Americans to make the ... habits more effective in helping Americans achieve better health. ... basis for federal food and nutrition education programs. "Issuing ...
... 29 Nutraceutical International Corporation (Nasdaq: NUTR ) today ... 31, 2008. Net sales for the fiscal 2009 first ... same quarter of fiscal 2008. For the first quarter ... diluted earnings per share, compared to net income of $3.2 ...
... Agencies that Rely on Send Word Now for Rapid, Reliable ... Inc., the leading provider of emergency notification and other on-demand ... of Health has expanded its use of Send Word Now ... extend its use of the SWN Alert Service across its ...
Cached Medicine News:Health News:Covidien Canada Streamlines Integration and Processing of Fax-based Orders With GHX G-Fax(TM) Fax Conversion Service 2Health News:Covidien Canada Streamlines Integration and Processing of Fax-based Orders With GHX G-Fax(TM) Fax Conversion Service 3Health News:CSC Introduces HealthSpace Advisor Benchmarking Tool 2Health News:CSC Introduces HealthSpace Advisor Benchmarking Tool 3Health News:The SCAN Foundation Grants $5 Million to the Health Technology Center to Establish National Center for Technology and Aging 2Health News:The SCAN Foundation Grants $5 Million to the Health Technology Center to Establish National Center for Technology and Aging 3Health News:American Dietetic Association Calls for Accountability in Dietary Guidelines for Americans to Make Them More Effective 2Health News:Nutraceutical Reports Fiscal 2009 Q1 Results 2Health News:Nutraceutical Reports Fiscal 2009 Q1 Results 3Health News:Nutraceutical Reports Fiscal 2009 Q1 Results 4Health News:Nutraceutical Reports Fiscal 2009 Q1 Results 5Health News:Nutraceutical Reports Fiscal 2009 Q1 Results 6Health News:Nutraceutical Reports Fiscal 2009 Q1 Results 7Health News:National Institutes of Health Expands Use of Emergency Notification Services Provided by Send Word Now(TM) Across NIH Campus 2Health News:National Institutes of Health Expands Use of Emergency Notification Services Provided by Send Word Now(TM) Across NIH Campus 3
... therapeutic system is optimally ... in mind. As an ... ongoing therapy, SONOCUR Basic ... effective therapy. Plus, the ...
... not only one of the most modern lithotripters ... Apart from being designed for the treatment of ... tract, the MODULITH SLX can also be employed ... is equally suitable for the treatment of gallstones ...
... MODULITH SLK follows a completely new and revolutionary ... a wide energy range for all indications of ... articulated arm. Different components of the treatment set-up ... can be chosen from a variety of brands ...
The latex free, hydrophilic Self-Cath Plus is designed for single use, intermittent self-catheterization. The unique hydrophilic coating activates immediately upon exposure to water for fast, clean...
Medicine Products: